-+ 0.00%
-+ 0.00%
-+ 0.00%

CARDIOL THERAPEUTICS INC - PHASE III MAVERIC TRIAL OF CARDIOLRX FULL ENROLLMENT EXPECTED IN Q2 2026

Reuters·04/01/2026 11:32:28

Please log in to view news